Comparison of genomes of brucella melitensis m28 and the b. melitensis m5-90 derivative vaccine strain highlights the translation elongation factor tu gene tuf2 as an attenuation-related gene

Infection and Immunity

Volumn 81, Issue 8, 2013, Pages 2812-2818

  Wang, Fangkun ^a,b   Qiao, Zujian ^a   Hu, Sen ^a   Liu, Wenxing ^a   Zheng, Huajun ^c   Liu, Sidang ^b   Zhao, Xiaomin ^b   Bu, Zhigao ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention   (China)

^c CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR TU;

ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BRUCELLA MELITENSIS; CONTROLLED STUDY; GENOME ANALYSIS; IN VIVO STUDY; INDEL MUTATION; MICROBIAL ATTENUATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN DIFFERENCE;

ANIMALS; BACTERIAL PROTEINS; BASE SEQUENCE; BRUCELLA MELITENSIS; BRUCELLA VACCINE; BRUCELLOSIS; FEMALE; GENOME, BACTERIAL; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE ELONGATION FACTOR TU; POLYMORPHISM, SINGLE NUCLEOTIDE; VACCINES, ATTENUATED; VIRULENCE;

EID: 84880964165     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00224-13     Document Type: Article

References (40)

1. Seleem MN, Boyle SM, Sriranganathan N. 2009. Brucellosis: a re-emerging zoonosis. Vet. Microbiol. 140:392-398.
2. Corbel MJ. 1997. Brucellosis: an overview. Emerg. Infect. Dis. 3:213-221.
3. Deqiu S, Donglou X, Jiming Y. 2002. Epidemiology and control of brucellosis in China. Vet. Microbiol. 90:165-182.
4. Cosivi O, Corbel MJ. 1998. WHO consultation on the development of new/improved brucellosis vaccines. 17 December 1997, Geneva, Switzerland. Biologicals 26:361-363.
5. Kaufmann AF, Meltzer MI, Schmid GP. 1997. The economic impact of abioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg. Infect. Dis. 3:83-94.
6. Wattam AR, Williams KP, Snyder EE, Almeida NF, Jr, Shukla M, Dickerman AW, Crasta OR, Kenyon R, Lu J, Shallom JM, Yoo H, Ficht TA, Tsolis RM, Munk C, Tapia R, Han CS, Detter JC, Bruce D, Brettin TS, Sobral BW, Boyle SM, Setubal JC. 2009. Analysis of ten Brucella genomes reveals evidence for horizontal gene transfer despite a preferred intracellular lifestyle. J. Bacteriol. 191:3569-3579.
7. Seleem MN, Boyle SM, Sriranganathan N. 2008. Brucella: a pathogen without classic virulence genes. Vet. Microbiol. 129:1-14.
8. Research Group of Brucellosis (Harbin Veterinary Research Institute). 1991. Study on the Brucella melitensis strain M5-90 vaccine. Chinese J. Control Endemic Dis. 6:65-68. (In Chinese.)
9. Wang F, Hu S, Gao Y, Qiao Z, Liu W, Bu Z. 2011. Complete genome sequences of Brucella melitensis strains M28 and M5-90, with different virulence backgrounds. J. Bacteriol. 193:2904-2905.
10. Saxena V, Garg S, Ranjan S, Kochar D, Ranjan A, Das A. 2007. Analysis of elongation factor Tu (tuf A) of apicoplast from Indian Plasmodium vivax isolates. Infect. Genet. Evol. 7:618-626.
11. Pruitt KD, Tatusova T, Maglott DR. 2007. NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 35:D61-D65.
12. Darling AC, Mau B, Blattner FR, Perna NT. 2004. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res. 14:1394-1403.
13. Nielsen K. 2002. Diagnosis of brucellosis by serology. Vet. Microbiol. 90:447-459.
14. Gibby IW, Gibby AM. 1964. Population dynamics of Brucella on solid media. Appl. Microbiol. 12:442-446.
15. De Schrijver J, De Leeneer K, Lefever S, Sabbe N, Pattyn F, Van Nieuwerburgh F, Coucke P, Deforce D, Vandesompele J, Bekaert S, Hellemans J, Van Criekinge W. 2010. Analysing 454 amplicon rese-quencing experiments using the modular and database oriented Variant Identification Pipeline. BMC Bioinformatics 11:269. doi: 10.1186/1471-2105-11-269.
16. Huse SM, Huber JA, Morrison HG, Sogin ML, Welch DM. 2007. Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol. 8:R143. doi:10.1186/gb-2007-8-7-r143.
17. Crasta OR, Folkerts O, Fei Z, Mane SP, Evans C, Martino-Catt S, Bricker B, Yu G, Du L, Sobral BW. 2008. Genome sequence of Brucella abortus vaccine strain S19 compared to virulent strains yields candidate virulence genes. PLoS One 3:e2193. doi:10.1371/journal.pone.0002193.
18. Drazek ES, Houng HS, Crawford RM, Hadfield TL, Hoover DL, Warren RL. 1995. Deletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages. Infect. Immun. 63: 3297-3301.
19. Shin GW, Nho SW, Park SB, Jang HB, Cha IS, Ha MA, Kim YR, Dalvi RS, Joh SJ, Jung TS. 2009. Comparison of antigenic proteins from Lac-tococcus garvieae KG- and KG+ strains that are recognized by olive flounder (Paralichthys olivaceus) antibodies. Vet. Microbiol. 139:113-120.
20. Sharma J, Mishra BB, Li Q, Teale JM. 2011. TLR4-dependent activation of inflammatory cytokine response in macrophages by Francisella elongation factor Tu. Cell. Immunol. 269:69-73.
21. Nieves W, Heang J, Asakrah S, Honer zu Bentrup K, Roy CJ, Morici LA. 2010. Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization. PLoS One 5:e14361. doi:10.1371/journal.pone.0014361.
22. Araujo FR, Costa CM, Ramos CA, Farias TA, Souza II, Melo ES, Elisei C, Rosinha GM, Soares CO, Fragoso SP, Fonseca AH. 2008. IgG and IgG2 antibodies from cattle naturally infected with Anaplasma marginale recognize the recombinant vaccine candidate antigens VirB9, VirB10, and elongation factor-Tu. Mem. Inst. Oswaldo Cruz 103:186-190.
23. Lopez JE, Palmer GH, Brayton KA, Dark MJ, Leach SE, Brown WC. 2007. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine. Infect. Immun. 75: 2333-2342.
24. Junior DS, Araujo FR, Almeida Junior NF, Adi SS, Cheung LM, Fragoso SP, Ramos CA, Oliveira RH, Santos CS, Bacanelli G, Soares CO, Rosinha GM, Fonseca AH. 2010. Analysis of membrane protein genes in a Brazilian isolate of Anaplasma marginale. Mem. Inst. Oswaldo Cruz 105:843-849.
25. Cardoso PG, Macedo GC, Azevedo V, Oliveira SC. 2006. Brucella spp noncanonical LPS: structure, biosynthesis, and interaction with host immune system. Microb. Cell Fact. 5:13. doi:10.1186/1475-2859-5-13.
26. Sangari FJ, Seoane A, Rodriguez MC, Aguero J, Garcia Lobo JM. 2007. Characterization of the urease operon of Brucella abortus and assessment of its role in virulence of the bacterium. Infect. Immun. 75:774-780.
27. Rajashekara G, Covert J, Petersen E, Eskra L, Splitter G. 2008. Genomic island 2 of Brucella melitensis is a major virulence determinant: functional analyses of genomic islands. J. Bacteriol. 190:6243-6252.
28. Wu Q, Pei J, Turse C, Ficht TA. 2006. Mariner mutagenesis of Brucella melitensis reveals genes with previously uncharacterized roles in virulence and survival. BMC Microbiol. 6:102. doi:10.1186/1471-2180-6-102.
29. Lavigne JP, O'Callaghan D, Blanc-Potard AB. 2005. Requirement of MgtC for Brucella suis intramacrophage growth: a potential mechanism shared by Salmonella enterica and Mycobacterium tuberculosis for adaptation to a low-Mg2+ environment. Infect. Immun. 73:3160-3163.
30. Loisel-Meyer S, Jimenez de Bagues MP, Basseres E, Dornand J, Kohler S, Liautard JP, Jubier-Maurin V. 2006. Requirement of norD for Brucella suis virulence in a murine model of in vitro and in vivo infection. Infect. Immun. 74:1973-1976.
31. Haine V, Sinon A, Van Steen F, Rousseau S, Dozot M, Lestrate P, Lambert C, Letesson JJ, De Bolle X. 2005. Systematic targeted mutagenesis of Brucella melitensis 16M reveals a major role for GntR regulators in the control of virulence. Infect. Immun. 73:5578-5586.
32. Hernandez-Castro R, Verdugo-Rodriguez A, Puente JL, Suarez-Guemes F. 2008. The BMEI0216 gene of Brucella melitensis is required for inter-nalization in HeLa cells. Microb. Pathog. 44:28-33.
33. Bandara AB, Schurig GG, Sriranganathan N, Prasad R, Boyle SM. 2009. The putative penicillin-binding proteins 1 and 2 are important for viability, growth and cell morphology of Brucella melitensis. Vet. Microbiol. 133:387-393.
34. Posadas DM, Martin FA, Sabio y Garcia JV, Spera JM, Delpino MV, Baldi P, Campos E, Cravero SL, Zorreguieta A. 2007. The TolC homo-logue of Brucella suis is involved in resistance to antimicrobial compounds and virulence. Infect. Immun. 75:379-389.
35. Dozot M, Boigegrain RA, Delrue RM, Hallez R, Ouahrani-Bettache S, Danese I, Letesson JJ, De Bolle X, Kohler S. 2006. The stringent response mediator Rsh is required for Brucella melitensis and Brucella suis virulence, and for expression of the type IV secretion system virB. Cell. Microbiol. 8:1791-1802.
36. Delrue RM, Deschamps C, Leonard S, Nijskens C, Danese I, Schaus JM, Bonnot S, Ferooz J, Tibor A, De Bolle X, Letesson JJ. 2005. A quorum-sensing regulator controls expression of both the type IV secretion system and the flagellar apparatus of Brucella melitensis. Cell. Microbiol. 7:1151-1161.
37. Paulley JT, Anderson ES, Roop RM, II. 2007. Brucella abortus requires the heme transporter BhuA for maintenance of chronic infection in BALB/c mice. Infect. Immun. 75:5248-5254.
38. Rambow-Larsen AA, Rajashekara G, Petersen E, Splitter G. 2008. Putative quorum-sensing regulator BlxR of Brucella melitensis regulates virulence factors including the type IV secretion system and flagella. J. Bacteriol. 190:3274-3282.
39. Kohler S, Foulongne V, Ouahrani-Bettache S, Bourg G, Teyssier J, Ramuz M, Liautard JP. 2002. The analysis of the intramacrophagic viru-lome of Brucella suis deciphers the environment encountered by the pathogen inside the macrophage host cell. Proc. Natl. Acad. Sci. U. S. A. 99:15711-15716.
40. Nasim A, Brychcy T. 1979. Genetic effects of acridine compounds. Mutat. Res. 65:261-288.